Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) reached a new 52-week low on Thursday after Royal Bank Of Canada lowered their price target on the stock from $28.00 to $22.00. Royal Bank Of Canada currently has an outperform rating on the stock. Acadia Healthcare traded as low as $16.91 and last traded at $17.2560, with a volume of 48066 shares traded. The stock had previously closed at $17.41.
Other equities research analysts have also recently issued reports about the company. Guggenheim lowered their target price on Acadia Healthcare from $29.00 to $27.00 and set a “buy” rating for the company in a report on Monday. Raymond James Financial set a $22.00 target price on Acadia Healthcare in a research report on Friday, November 7th. Cantor Fitzgerald decreased their price target on shares of Acadia Healthcare from $25.00 to $22.00 and set a “neutral” rating for the company in a research note on Friday, November 7th. Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a research report on Wednesday, October 8th. Finally, UBS Group reduced their price target on shares of Acadia Healthcare from $31.00 to $28.00 and set a “buy” rating for the company in a research report on Friday, November 7th. Eight investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $32.82.
Check Out Our Latest Stock Report on Acadia Healthcare
Institutional Inflows and Outflows
Acadia Healthcare Price Performance
The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.73. The business has a fifty day simple moving average of $23.02 and a two-hundred day simple moving average of $22.71. The stock has a market cap of $1.57 billion, a PE ratio of 11.26, a P/E/G ratio of 4.56 and a beta of 0.97.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last issued its quarterly earnings data on Wednesday, November 5th. The company reported $0.72 EPS for the quarter, topping the consensus estimate of $0.71 by $0.01. The company had revenue of $851.57 million during the quarter, compared to analyst estimates of $852.43 million. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.Acadia Healthcare’s revenue was up 4.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.91 earnings per share. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. Research analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.
About Acadia Healthcare
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Recommended Stories
- Five stocks we like better than Acadia Healthcare
- 3 Warren Buffett Stocks to Buy Now
- 4 High-Yield Real Estate Stocks to Buy as Investors Get Defensive
- Breakout Stocks: What They Are and How to Identify Them
- Oklo’s Meltdown Is Over: A Robust Rebound Lies Ahead
- How Investors Can Find the Best Cheap Dividend Stocks
- 3 Reasons On Holding’s Sell-Off Is Over and New Highs Are Coming
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
